SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-24-011117
Filing Date
2024-03-04
Accepted
2024-03-04 17:25:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 ny20019103x1_424b5.htm 424B5 573561
2 logo_bridgebio.jpg GRAPHIC 58301
  Complete submission text file 0001140361-24-011117.txt   654814
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-271650 | Film No.: 24716070
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)